The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: A prospective observational study

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 7, 2013, Pages 1535-1542

  Tsantes, Argirios ^a   Tsangaris, Iraklis ^a   Kopterides, Petros ^a   Kapsimali, Violetta ^b   Antonakos, Georgios ^c   Zerva, Aikaterini ^c   Kalamara, Eleni ^a   Bonovas, Stefanos ^d   Tsaknis, George ^a   Vrigou, Eleni ^a   Maniatis, Nikolaos ^a   Dima, Kleanthi ^c   Armaganidis, Apostolos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d Hellenic Centre for Disease Control and Prevention   (Greece)

Author keywords

acute respiratory distress syndrome; biochemical marker; IL 6; procalcitonin; sepsis

Indexed keywords

INTERLEUKIN 6; PROCALCITONIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AREA UNDER THE CURVE; ARTICLE; ASPIRATION; CONCENTRATION (PARAMETERS); DEMOGRAPHY; DRUG OVERDOSE; FEMALE; FORECASTING; HUMAN; INJURY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECOGNITION; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; TRANSFUSION;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CALCITONIN; EARLY DIAGNOSIS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RESPIRATORY DISTRESS SYNDROME, ADULT; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84882971900     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0562     Document Type: Article

References (39)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8. (Pubitemid 23066085)
2. Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996;128:570-3. (Pubitemid 26114804)
3. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000;26:1193-200.
4. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504. (Pubitemid 29162669)
5. Clecah C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004;32:1166-9. (Pubitemid 38620986)
6. Ruokonen E, Ilkka L, Niskansen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anesthesiol Scand 2002;46:398-404. (Pubitemid 34454435)
7. Tsangaris I, Plachouras D, Kavatha D, Gourgoulis GM, Tsantes A, Kopterides P, et al. Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis 2009;9:213.
8. Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C, et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 2012;40:2304-9.
9. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systemic review and meta-analysis. Crit Care Med 2006;34:1996-2003. (Pubitemid 43982479)
10. Tang B, Eslick G, Craig J, McLean A. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: A systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7. (Pubitemid 46274517)
11. Ware LB, Matthay MA. Medical progress: The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49. (Pubitemid 30408719)
12. Brunkhorst F, Eberhard O, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999;27:2172-6. (Pubitemid 29508332)
13. Schütte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996;9:1858-67. (Pubitemid 26294756)
14. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: Plasma IL-1b and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-73.
15. Lin WC, Lin CF, Chen CL, Chen CW, Lin YS. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med (Maywood) 2010;235:57-65.
16. Miguel-Bayarri V, Casanoves-Laparra EB, Pall ás-Beneyto L, Sancho-Chinesta S, Mart ín-Osorio LF, Tormo-Calandín C, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva 2012;36:556-62.
17. Tsangaris I, Tsantes A, Bonovas S, Lignos M, Kopterides P, Gialeraki A, et al. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res 2009;123:832-6.
18. Tsangaris I, Tsantes A, Bagos P, Nikolopoulos G, Kroupis C, Kopterides P, et al. The effect of plasma homocysteine levels on clinical outcomes of patients with ALI/ARDS. Am J Med Sci 2009;338:474-7.
19. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24. (Pubitemid 24082248)
20. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
21. Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition conference. Crit Care Med 2003;31:1250-6. (Pubitemid 36444440)
22. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med 2006;174:84-93. (Pubitemid 43955248)
23. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903. (Pubitemid 34774654)
24. Vincent JL. Ventilator-associated pneumonia. J Hosp Infect 2004;57:272-80.
25. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997;15:148-51. (Pubitemid 27147031)
26. Calandra T, Cohen J. International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definitions of infections in the intensive care unit. Crit Care Med 2005;33:1538-48. (Pubitemid 40980610)
27. Bansal J, Jenaw RK, Rao J, Kankaria J, Agrawal NN. Effectiveness of plain radiography in diagnosing hollow viscus perforation: Study of 1,723 patients of perforation peritonitis. Emerg Radiol 2012;19:115-9.
28. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, editor. APIC Infection control and applied epidemiology: Principles and practice. St. Louis: Mosby, 1996:A1-20.
29. Tsantes A, Tsangaris I, Nikolopoulos G, Bagos P, Kopterides P, Antonakos G, et al. The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis. Minerva Anestesiol 2010;76:787-94.
30. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000;28:950-7. (Pubitemid 30262061)
31. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8.
32. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86: 396-404. (Pubitemid 32109825)
33. Yokoi K, Mukaida N, Harada A, Watanabe Y, Matsushima K. Prevention of endotoxinaemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 1997;76:375-84. (Pubitemid 27157345)
34. Stilleto R, Baacke M, Gotzen L, Lefering R, Renz H. Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion. Crit Care Med 2001;29:1690-3. (Pubitemid 32848366)
35. Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator associated pneumonia. Ann Clin Biochem 2008;45:293-8. (Pubitemid 351724566)
36. Duflo F, Debon R, Monneret C, Bienvenu J, Chassard D, Allaouchiche B. Alveolar and serum procalcitonin: Diagnostic and prognostic value in ventilator associated pneumonia. Anesthesiology 2002;96:74-9. (Pubitemid 34032485)
37. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin and C-reactive protein plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999;3:45-50. (Pubitemid 29304058)
38. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003;31:1737-41. (Pubitemid 36714230)
39. Kushimoto S, Shibata Y, Koido Y, Kawai M, Yokota H, Yamamoto Y. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy. J Nippon Med Sch 2007;74:236-40. (Pubitemid 47013718)